Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revive Therapeutics Ltd (TSE:RVV)
CNQX:RVV
Revive Therapeutics (RVV) Stock Price & Analysis
119 Followers
RVV Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.18
Previous CloseC$0.03
Volume114.17K
Average Volume (3M)158.99K
Market Cap
C$10.73M
Enterprise ValueC$8.86M
Total Cash (Recent Filing)C$2.09M
Total Debt (Recent Filing)C$219.69K
Price to Earnings (P/E)-1.6
Beta0.48
Next Earnings
Feb 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding357,646,841
10 Day Avg. Volume121,711
30 Day Avg. Volume158,988
Standard Deviation0.38
R-Squared0.00125
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-10.02
Price to Sales (P/S)-31.54
Price to Cash Flow (P/CF)-4.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Revive Therapeutics News
Ownership Overview
4.70%
Insiders
0.00% Mutual Funds
0.01% Other Institutional Investors
95.29% Public Companies and
Individual Investors
RVV FAQ
What was Revive Therapeutics Ltd’s price range in the past 12 months?
Revive Therapeutics Ltd lowest stock price was C$0.02 and its highest was C$0.17 in the past 12 months.
What is Revive Therapeutics Ltd’s market cap?
Currently, no data Available
When is Revive Therapeutics Ltd’s upcoming earnings report date?
Revive Therapeutics Ltd’s upcoming earnings report date is Feb 28, 2024 which is in 88 days.
How were Revive Therapeutics Ltd’s earnings last quarter?
Currently, no data Available
Is Revive Therapeutics Ltd overvalued?
According to Wall Street analysts Revive Therapeutics Ltd’s price is currently Overvalued.
Does Revive Therapeutics Ltd pay dividends?
Revive Therapeutics Ltd does not currently pay dividends.
What is Revive Therapeutics Ltd’s EPS estimate?
Revive Therapeutics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Revive Therapeutics Ltd have?
Revive Therapeutics Ltd has 357,646,850 shares outstanding.
What happened to Revive Therapeutics Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Revive Therapeutics Ltd?
Currently, no hedge funds are holding shares in TSE:RVV
---
Revive Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.85%
12-Months-Change
Fundamentals
Return on Equity
-54.36%
Trailing 12-Months
Asset Growth
-16.49%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Revive Therapeutics Ltd
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---